If you’re running anything oral and 17-alpha-alkylated — anavar, winstrol, dianabol, halotestin, anadrol — you are absolutely beating up your liver. The conventional bro-supplement answer is milk thistle, which is fine but underwhelming. The Enhanced Man’s answer is TUDCA, and the gap in effectiveness isn’t close.
What Is TUDCA?
TUDCA is tauroursodeoxycholic acid — a hydrophilic bile acid produced naturally in tiny amounts in your body, conjugated with the amino acid taurine. It’s been used in traditional Chinese medicine for over 3,000 years as bile from black bears (a fact that thankfully no longer applies; modern TUDCA is synthesized).
It’s the pharmaceutical-grade cousin of UDCA (ursodeoxycholic acid, brand name Actigall/Ursodiol), which is FDA-approved for primary biliary cholangitis and gallstone dissolution. TUDCA is more bioavailable and slightly more potent than UDCA.
Why Liver Protection Matters On Cycle
17-alpha-alkylation is the chemical modification that lets oral steroids survive first-pass liver metabolism. The cost: every dose of an oral 17aa is essentially a controlled chemical insult to hepatocytes. Markers of hepatic stress accumulate fast:
- ALT and AST elevation (often 2-5x upper limit of normal within weeks)
- Cholestasis — bile flow impairment
- Lipid panel disruption (sharp HDL drop, LDL elevation)
- Risk of peliosis hepatis at extreme/prolonged use
TUDCA addresses every one of these mechanisms.
Mechanism of Action
1. ER Stress Reduction
Endoplasmic reticulum stress is one of the primary drivers of hepatocyte injury during oral steroid exposure. TUDCA is one of the most potent endogenous and exogenous reducers of ER stress identified — it stabilizes ER membranes, reduces unfolded protein response signaling, and prevents apoptosis of stressed hepatocytes.
2. Bile Flow Enhancement
Oral steroids cause cholestasis — bile becomes thick and stagnant, backing up into the liver and causing damage. TUDCA increases bile flow (choleretic effect) and changes the bile acid pool to a less hepatotoxic composition.
3. Mitochondrial Membrane Stabilization
TUDCA stabilizes mitochondrial membranes and prevents the mitochondrial permeability transition that triggers apoptosis cascades in stressed cells.
4. Anti-Apoptotic Signaling
It modulates Bcl-2 family proteins to favor cell survival in stressed hepatocytes — the cells get a chance to recover rather than die.
Dosing Protocol
On-Cycle Liver Support
- Dose: 500-1000 mg per day
- Timing: Split into 2 doses, with food
- Duration: Throughout cycle and for 2-4 weeks post-cycle
Healthy Maintenance Dose
- Dose: 250 mg per day
- Use case: Periodic detox, gallbladder support, ongoing liver insurance
Acute Liver Stress Recovery
- Dose: 1000-1500 mg per day for 4-8 weeks
- Use case: Recovering from significant alcohol exposure, drug-induced injury, or extreme oral cycles
What to Expect
TUDCA is one of the few supplements where bloodwork shows a clear, measurable effect. Run liver enzymes before and 4 weeks into supplementation:
- ALT and AST often drop 30-60% in users with elevated baseline
- GGT improvements
- Reduced bilirubin if elevated
- Improved bile flow may reduce digestive issues, especially with fatty foods
Stacking for Liver Protection
TUDCA is the foundation. Smart stacks add complementary mechanisms:
- + NAC (N-acetyl cysteine) 1200-1800 mg/day — glutathione precursor, addresses oxidative stress
- + Milk Thistle (silymarin standardized) 200-400 mg/day — anti-fibrotic, antioxidant
- + Choline (alpha-GPC or CDP-choline) — supports lipid export from liver, reduces fatty liver risk
- + Berberine — improves insulin sensitivity, reduces hepatic glucose output
- + Fish oil at 3-5 g/day — improves lipid panel disruption from orals
Beyond On-Cycle: Other Use Cases
- Fatty liver disease (NAFLD/MASLD) — emerging research supports TUDCA for steatohepatitis
- Gallstones — TUDCA can help dissolve cholesterol stones over months
- Neurological protection — ER stress reduction has applications in ALS, Parkinson’s, retinal degeneration (active research areas)
- Insulin resistance — modest improvements in metabolic markers
Side Effects
TUDCA is exceptionally well tolerated. Mild GI effects in some users at high doses:
- Loose stools or diarrhea (rare, dose-dependent)
- Mild stomach upset if taken on empty stomach
- Possible interaction with cholestyramine and similar bile acid binders
Who Should Run TUDCA
- Anyone using oral 17aa anabolic compounds
- Heavy alcohol consumers (although fixing the alcohol is the bigger priority)
- Patients with elevated baseline liver enzymes
- Anyone with NAFLD or pre-NAFLD picture on imaging
- Polypharmacy patients with hepatically metabolized medications
Bloodwork Monitoring
Run a comprehensive metabolic panel including ALT, AST, ALP, GGT, bilirubin (total and direct), and albumin before any cycle. Recheck mid-cycle and 4 weeks post-cycle. See the Bloodwork guide for complete reference ranges.
Tony Huge’s Take
The first law of biochemistry Physics applies: the body adapts to whatever you throw at it. Throw oral steroids and skip liver protection, and the adaptation is hepatocyte injury that compounds over years of cycling. Throw the same compounds with TUDCA + NAC + the rest of a smart support stack, and the adaptation is dramatically more favorable. the enhanced man doesn’t get away with avoiding bloodwork or skipping support. He runs both. Hard.
Ready to optimize? Explore the full Enhanced Athlete Protocol for a structured approach to peptides, hormones, training, and recovery built on Tony Huge’s years of self-experimentation.